Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 10,256 | 3,110 | 3,811 | 3,680 | 3,260 |
| Operating Income | -10,256 | -3,110 | -3,811 | -3,680 | -3,260 |
| Other Income | 145 | 73 | 95 | 117 | 82 |
| Pre-tax Income | -10,111 | -3,037 | -3,716 | -3,563 | -3,178 |
| Net Income Continuous | -10,111 | -3,037 | -3,716 | -3,563 | -3,178 |
| Net Income | $-10,111 | $-3,037 | $-3,716 | $-3,563 | $-3,178 |
| EPS Basic Total Ops | -0.23 | -0.41 | -0.66 | -1.61 | -2.41 |
| EPS Basic Continuous Ops | -0.23 | -0.41 | -0.66 | -1.61 | -2.40 |
| EPS Diluted Total Ops | -0.23 | -0.41 | -0.66 | -1.61 | -2.41 |
| EPS Diluted Continuous Ops | -0.23 | -0.41 | -0.66 | -1.61 | -2.40 |
| EPS Diluted Before Non-Recurring Items | -0.89 | -0.41 | -0.66 | -1.61 | -2.41 |
| EBITDA(a) | $-10,099 | $-2,929 | $-3,649 | $-3,519 | $-3,097 |